<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.healthcaretribunefrance.com/article/906534059-ascendo-ai-brings-ai-resolve-to-google-cloud-marketplace</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Tribune France</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T16:44:15+00:00</news:publication_date>
        <news:title>Ascendo AI Brings AI Resolve to Google Cloud Marketplace </news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.healthcaretribunefrance.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Tribune France</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T10:00:00+00:00</news:publication_date>
        <news:title>Press Release: ESCMID: Sanofi&#39;s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcaretribunefrance.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Tribune France</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T10:00:00+00:00</news:publication_date>
        <news:title>Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
